Health

Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs
Health

Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs

Zoom In IconArrows pointing outwards The direct-to-consumer health-care startup Ro launched a new free tool Tuesday to help patients determine whether their insurance covers a buzzy class of weight loss and diabetes drugs called GLP-1s.  Most insurance plans cover GLP-1s when they are used to treat diabetes, so those patients can usually avoid the roughly […]

Read More
U.S. track star Noah Lyles takes bronze in 200-meter, says he tested positive for Covid
Health

U.S. track star Noah Lyles takes bronze in 200-meter, says he tested positive for Covid

Botswana’s Letsile Tebogo, US’ Kenneth Bednarek and US’ Noah Lyles cross the finish line to finish first, second and third respectively in the men’s 200m final of the athletics event at the Paris 2024 Olympic Games at Stade de France in Saint-Denis, north of Paris, on August 8, 2024. Odd Andersen | AFP | Getty […]

Read More
Eli Lilly blows past estimates, hikes guidance as Zepbound, Mounjaro sales soar
Health

Eli Lilly blows past estimates, hikes guidance as Zepbound, Mounjaro sales soar

The Eli Lilly logo is shown on one of the company’s offices in San Diego, California, on Sept. 17, 2020. Mike Blake | Reuters Eli Lilly on Thursday reported second-quarter earnings and revenue that blew past expectations and hiked its full-year revenue outlook by $3 billion as sales of its blockbuster diabetes drug Mounjaro and […]

Read More
Eli Lilly reports earnings Thursday. Here’s what Wall Street is watching
Health

Eli Lilly reports earnings Thursday. Here’s what Wall Street is watching

Investors want to know whether Eli Lilly is seeing the same pricing pressures on its blockbuster weight loss drug Zepbound that Novo Nordisk experienced with its competing drug Wegovy in the second quarter. Novo Nordisk shocked investors on Wednesday when its latest results fell short of Wall Street’s expectations. Shares are reeling, down 8%, after […]

Read More
CVS slashes profit outlook on higher medical costs, says top Aetna executive will leave
Health

CVS slashes profit outlook on higher medical costs, says top Aetna executive will leave

The CVS pharmacy logo is displayed on a sign above a CVS Health Corp. store in Las Vegas, Nevada on Feb. 7, 2024. Patrick T. Fallon | AFP | Getty Images CVS Health on Wednesday reported second-quarter earnings that topped expectations, but slashed its full-year profit outlook, citing higher medical costs that have been squeezing […]

Read More
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
Health

Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare

President Joe Biden speaks during an event at the National Institutes of Health in Bethesda, Maryland, Dec. 14, 2023. Chris Kleponis | Bloomberg | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! The first round of Medicare drug price negotiations has come […]

Read More
Eli Lilly’s Zepbound and Mounjaro now available in U.S. after shortages, FDA says
Health

Eli Lilly’s Zepbound and Mounjaro now available in U.S. after shortages, FDA says

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters All doses of Eli Lilly’s highly popular weight loss injection Zepbound and diabetes drug Mounjaro are now available in the U.S., according to an update on the U.S. Food and Drug […]

Read More
Eli Lilly’s weight loss drug Zepbound cuts heart failure risks in late-stage study
Health

Eli Lilly’s weight loss drug Zepbound cuts heart failure risks in late-stage study

An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March 28, 2024.  Shelby Knowles | Bloomberg | Getty Images Eli Lilly‘s weight loss drug Zepbound showed benefits in patients with a common type of heart failure and obesity, according to late-stage trial data the company […]

Read More
Biogen beats expectations, hikes outlook as Alzheimer’s drug Leqembi and other new products gain traction
Health

Biogen beats expectations, hikes outlook as Alzheimer’s drug Leqembi and other new products gain traction

A test tube is seen in front of displayed Biogen logo in this illustration taken on, December 1, 2021. Dado Ruvic | Reuters Biogen on Thursday reported second-quarter earnings and revenue that topped estimates and hiked its full-year guidance, as the company’s cost cuts showed progress and sales of its breakthrough Alzheimer’s drug, Leqembi, and […]

Read More
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
Health

Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes

Weight loss syringes of the brands “Wegovy”, “Ozempic” and “Mounjaro” are sold at In der Achat Apotheke in Mitte, Germany. Picture Alliance | Picture Alliance | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! The list of potential health benefits from […]

Read More